Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
type: MedicalStudy
description: Phase III Study Of Gemcitabine, Dexamethasone, And Cisplatin Compared To Dexamethasone, Cytarabine, And Cisplatin Plus/Minus Rituximab [(R)-GDP vs (R)-DHAP] As Salvage Chemotherapy For Patients With Relapsed Or Refractory Aggressive Histology Non-Hodgkin's Lymphoma Prior To Autologous Stem Cell Transplant And Followed By Maintenance Rituximab vs Observation
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2003-08-27
end date: 2018-12
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00078949
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: NCIC Clinical Trials Group
study subject: Lymphoma
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Lymphoma

AI Analytics
type: Organization